Skip to main content

Diagnosis of Addiction, Substance Use, and Headache

  • Chapter
  • First Online:
The Cleveland Clinic Manual of Headache Therapy

Abstract

A large proportion of patients who visit headache specialists suffer from chronic headache disorders, many of which are refractory to conventional therapy. In addition to the epidemic of common analgesic overuse, many patients medicate themselves with controlled substances, such as opioids, benzodiazepines, barbiturates, and other sedative hypnotics. Some of these medications have been prescribed by practitioners for either a pain-related or a comorbid condition, while some medications have been obtained illegally, without the knowledge of their doctors.

In order to properly treat these patients, and to effectively eliminate unnecessary medications, the practitioner must be aware not only of all of the patient’s comorbid medical conditions but also of all the medications the patient uses. This includes prescription analgesics, nonprescription analgesics, and illegal agents. With the current spate of both prescription and recreational opioid-related drug overdoses and suicides, it is incumbent on the headache doctor to be cognizant of aberrant drug-related behaviors. The headache physician should know where and how to obtain help for patients at risk of, or exhibiting, addictive behaviors. This chapter discusses these therapeutic options.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Suggested Reading

  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Washington, DC: American Psychiatric Association; 2013.

    Google Scholar 

  • Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008;48:1157–68.

    Google Scholar 

  • Dunbar SA, Katz NP Chronic opioid therapy for nonmalignant pain in patients with a history of substance abuse: report of 20 cases. J Pain Symptom Manage. 1996;11:163–171.

    Google Scholar 

  • England JD, Franklin GM. Difficult decisions: managing chronic neuropathic pain with opioids. Continuum  (Minneap Minn). 2012;18:181–4.

    Google Scholar 

  • Manchikanti L, Ailinani H, Koyyalagunta D, Datta S, Singh V, Eriator I, Sehgal N, Shah R, Benyamin R, Vallejo R, Fellows B, Christo PJ. A systematic review of randomized trials of long-term opioid management for chronic non-cancer pain. Pain Physician. 2011;14:91–121.

    Google Scholar 

  • Saper JR, Lake AE 3rd, Bain PA, Stillman MJ, Rothrock JF, Mathew NT, Hamel RL, Moriarty M, Tietjen GE. A practice guide for continuous opioid therapy for refractory daily headache: patient selection, physician requirements, and treatment monitoring. Headache. 2010;50:1175–93.

    Google Scholar 

  • Saper JR, Lake AE 3rd. Continuous opioid therapy (COT) is rarely advisable for refractory chronic daily headache: Limited efficacy, risks, and proposed guidelines. Headache. 2008;48:838–849.

    Google Scholar 

  • Savage SR, Joranson DE, Covington EC, Schnoll SH, Heit HA, Gilson AM. Definitions related to the medical use of opioids: Evolution towards universal agreement. Journal of Pain and Symptom Management. 2003;26:655–67.

    Google Scholar 

  • Sehgal N, Manchikanti L, Smith HS. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse. Pain Physician. 2012;15(Suppl):ES67–92.

    Google Scholar 

  • Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6:432–42.

    Google Scholar 

  • Yang M, Rendas-Baum R, Varon SF, Kosinski M. Validation of the Headache Impact Test (HIT-6) across episodic and chronic migraine. Cephalalgia. 2011;31:357–67.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mark J. Stillman MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Stillman, M., Kriegler, J., Covington, E., Krause, S. (2014). Diagnosis of Addiction, Substance Use, and Headache. In: Tepper, S., Tepper, D. (eds) The Cleveland Clinic Manual of Headache Therapy. Springer, Cham. https://doi.org/10.1007/978-3-319-04072-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-04072-1_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-04071-4

  • Online ISBN: 978-3-319-04072-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics